Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Colon cancer (CC) pathological staging fails to accurately predict recurrence, and to date, no gene expression signature has proven reliable for prognosis stratification in clinical practice, perhaps because CC is a heterogeneous disease. The aim of this study was to establish a comprehensive molecular classification of CC based on mRNA expression profile analyses. METHODS AND FINDINGS: Fresh-frozen primary tumor samples from a large multicenter cohort of 750 patients with stage I to IV CC who underwent surgery between 1987 and 2007 in seven centers were characterized for common DNA alterations, including BRAF, KRAS, and TP53 mutations, CpG island methylator phenotype, mismatch repair status, and chromosomal instability status, and were screened with whole genome and transcriptome arrays. 566 samples fulfilled RNA quality requirements. Unsupervised consensus hierarchical clustering applied to gene expression data from a discovery subset of 443 CC samples identified six molecular subtypes. These subtypes were associated with distinct clinicopathological characteristics, molecular alterations, specific enrichments of supervised gene expression signatures (stem cell phenotype-like, normal-like, serrated CC phenotype-like), and deregulated signaling pathways. Based on their main biological characteristics, we distinguished a deficient mismatch repair subtype, a KRAS mutant subtype, a cancer stem cell subtype, and three chromosomal instability subtypes, including one associated with down-regulated immune pathways, one with up-regulation of the Wnt pathway, and one displaying a normal-like gene expression profile. The classification was validated in the remaining 123 samples plus an independent set of 1,058 CC samples, including eight public datasets. Furthermore, prognosis was analyzed in the subset of stage II-III CC samples. The subtypes C4 and C6, but not the subtypes C1, C2, C3, and C5, were independently associated with shorter relapse-free survival, even after adjusting for age, sex, stage, and the emerging prognostic classifier Oncotype DX Colon Cancer Assay recurrence score (hazard ratio 1.5, 95% CI 1.1-2.1, p = 0.0097). However, a limitation of this study is that information on tumor grade and number of nodes examined was not available. CONCLUSIONS: We describe the first, to our knowledge, robust transcriptome-based classification of CC that improves the current disease stratification based on clinicopathological variables and common DNA markers. The biological relevance of these subtypes is illustrated by significant differences in prognosis. This analysis provides possibilities for improving prognostic models and therapeutic strategies. In conclusion, we report a new classification of CC into six molecular subtypes that arise through distinct biological pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Summary of the main characteristics of the six subtypes. Symbols correspond to the relative frequency within the subtype (o: very low frequencies [∼0%]; +++: very high frequencies; +/++: intermediate frequencies), and arrows indicate significant enrichment of subtype up- and down-regulated genes in most of the pathways of the given category. EMT, epithelial–mesenchymal transition; SC, stem cell; Wnt pw, Wnt pathway.](https://figures.cochat.ai/paper-figures/d9e6ea3312ee4d83b17b55c403c90fdb/gene-expression-classification-of-colon-cancer-into-molecular-subtypes-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similar results were seen in Marisa 458 CMS1-4 CRC tumors (Fig. 8d).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116 · cited 1×
“To obtain a robust classification, we used a consensus unsupervised approach [22] implemented in the R package ConsensusClusterPlus.”
MethodWeisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Research works printed but not linked: 1
- American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven.
Cited by
Items 701–800 of 1,001
Lawlor, N. T., Fabbri, A., Guan, P., George, J., & Karuturi, R. K. M. (2016) · Cancer Informatics · doi:10.4137/cin.s38000 · Cited by 15
Beyond cancer genes: colorectal cancer as robust intrinsic states formed by molecular interactions
Yuan, R., Zhang, S., Yu, J., Huang, Y., Lu, D., Cheng, R., Huang, S., Ao, P., Zheng, S. S., Hood, L., et al. (2017) · Open Biology · doi:10.1098/rsob.170169 · Cited by 15
Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?
Athauda, A., Segelov, E., Ali, Z., & Chau, I. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.12.004 · Cited by 15
Clinical Implications of Mismatch Repair Status in Patients With High-risk Stage II Colon Cancer
Baek, D. W., Kang, B. W., Lee, S. J., Kim, H. J., Park, S. Y., Park, J. S., Choi, G., Baek, J. H., & Kim, J. G. (2019) · In Vivo · doi:10.21873/invivo.11523 · Cited by 15
Lv, Y., Xie, B., Bai, B., Shan, L., Zheng, W., Huang, X., & Zhu, H. (2019) · Oncology Reports · doi:10.3892/or.2019.7368 · Cited by 15
Ubink, I., Bloemendal, H. J., Elias, S. G., Brink, M. A., Schwartz, M. P., Holierhoek, Y. C. W., Verheijen, P. M., Boerman, A. W., Mathijssen, R. H. J., de Leng, W. W. J., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3264-y · Cited by 14
Ke, Q., Wang, Y., Deng, Y., Wang, J., Yuan, M., Liang, A., Wang, J., & Gong, Q. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-785 · Cited by 14
Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer
Qin, J., Hu, S., Lou, J., Xu, M., Gao, R., Xiao, Q., Chen, Y., Ding, M., Pan, Y., & Wang, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112487 · Cited by 14
Transcriptional mimicry by tumor-associated stroma
Kim, H., & Verhaak, R. G. W. (2015) · Nature Genetics · doi:10.1038/ng.3255 · Cited by 14
Lawler, M., Johnston, B., Schaeybroeck, S. V., Salto‐Tellez, M., Wilson, R. H., Dunlop, M. G., & Johnston, P. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00074-8 · Cited by 14
Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer
Xie, L., Huang, R., Huang, H., Liu, X., & Yu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.879751 · Cited by 14
Robles, J., Pintado‐Berninches, L., Boukich, I., Escudero, B., Ríos, V. D. L., Bartolomé, R. A., Jaén, M., Martín‐Regalado, Á., Fernández‐Aceñero, M. J., Imbaud, J. I., et al. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.294 · Cited by 14
Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients
Yue, T., Cai, Y., Zhu, J., Liu, Y., Chen, S., Wang, P., & Rong, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1064704 · Cited by 14
Zhu, J., Zhang, W., Chang, J., Wu, J., Wu, H., Zhang, X., Ou, Z., Tang, T. F., Li, L., Liu, M., et al. (2023) · Journal of Cancer · doi:10.7150/jca.81811 · Cited by 14
Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in colon cancer
Zhou, L., Zhang, Y., Wei, M., Du, K., Lin, J., & Wei, L. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02896-z · Cited by 14
Zhang, S., McCrudden, C. M., Yuen, H., Leung, K. L., Hong, W., & Kwok, H. F. (2015) · Oncology Letters · doi:10.3892/ol.2015.3999 · Cited by 14
Downregulation of PTPRH (Sap-1) in colorectal tumors
Bujko, M., Kober, P., Statkiewicz, M., Mikuła, M., Grecka, E., Rusetska, N., Ligaj, M., Ostrowski, J., & SIEDLECKI, J. A. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4068 · Cited by 14
Epsi, N. J., Panja, S., Pine, S. R., & Mitrofanova, A. (2019) · Communications Biology · doi:10.1038/s42003-019-0572-6 · Cited by 14
Sohier, P., Sanson, R., Leduc, M., Audebourg, A., Broussard, C., Salnot, V., Just, P., Pasmant, É., Mayeux, P., Guillonneau, F., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5366 · Cited by 14
Common cancer biomarkers of breast and ovarian types identified through artificial intelligence
Pawar, S., Liew, T. O., Stanam, A., & Lahiri, C. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13672 · Cited by 14
Bridging the gap between cancer cell line models and tumours using gene expression data
Noorbakhsh, J., Vázquez, F., & McFarland, J. M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01359-0 · Cited by 14
BRAF Gene Mutation Analysis in Colorectal Cancer in South of Iran
Javadi, F., Geramizadeh, B., & Mirzai, M. (2014) · Annals of Colorectal Research · doi:10.17795/acr-19917 · Cited by 14
Xu, G., Zhou, Y., & Zhou, F. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174452 · Cited by 13
Feng, J., Fu, F., & Nie, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1121634 · Cited by 13
Taşkıran, A. E. G., Karaoğlu, D. A., Eylem, C. C., Ermiş, Ç., Güderer, İ., Nemutlu, E., Canlı, S. D., & Banerjee, S. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102078 · Cited by 13
NANS suppresses NF-κB signaling to promote ferroptosis by perturbing iron homeostasis
Wang, Z., Di, Y., Ye, L., Fang, W., Wen, X., Zhang, X., Qin, J., Wang, Y., Hu, K., Zhu, Z., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115701 · Cited by 14
Modeling colorectal cancers using multidimensional organoids
Sayed, I. M., El‐Hafeez, A. A. A., Maity, P. P., Das, S., & Ghosh, P. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.005 · Cited by 13
Zhong, C., Xie, T., Chen, L., Zhong, X., Li, X., Cai, X., Chen, K., & Lan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983636 · Cited by 13
Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers
Alnuaimi, A. R., Nair, V. A., Malhab, L. J. B., Abu‐Gharbieh, E., Ranade, A. V., Pintus, G., Hamad, M., Busch, H. S., Kirfel, J., Hamoudi, R., et al. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i9.1637 · Cited by 13
Tong, Z., Wang, X., Shi, S., Hou, T., Gao, G., Li, D., Shan, Y., & Zhang, C. (2023) · Cancer Medicine · doi:10.1002/cam4.5682 · Cited by 13
Molecular portraits of colorectal cancer morphological regions
Budínská, E., Hrivňáková, M., Ivković, T. C., Mądrzyk, M., Nenutil, R., Bencsiková, B., Tukmachi, D. A., Ruckova, M., Dubská, L. Z., Slabý, O., et al. (2023) · eLife · doi:10.7554/elife.86655 · Cited by 13
Mares-Quiñones, M. D., Galán-Vásquez, E., Pérez‐Rueda, E., Pérez-Ishiwara, D. G., Medel-Flores, M. O., & Gómez-García, M. D. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-61908-4 · Cited by 13
Sayagués, J. M., del Carmen, S., Abad, M., Corchete, L. A., Bengoechea, Ó., Anduaga, M. F., Baldeón, M. J., Cruz, J. J., Alcázar, J. A. S., Angoso, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25300 · Cited by 13
Kong, X., Li, Y., & Zhang, X. (2018) · Medical Science Monitor · doi:10.12659/msm.908173 · Cited by 13
Gene pair based prognostic signature for colorectal colon cancer
Shu, P., Wu, J., Tong, Y., Xu, C., & Zhang, X. (2018) · Medicine · doi:10.1097/md.0000000000012788 · Cited by 13
Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location
Cannon, E. E., & Buechler, S. A. (2019) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.02.002 · Cited by 13
The role of transcription factor caudal-related homeobox transcription factor 2 in colorectal cancer
Wu, C.-C., Hsu, T.-W., Yeh, C.-C., & Huang, H.-B. (2020) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_49_20 · Cited by 13
KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer
Cabot, D., Brun, S., Paco, N., Morell, M., Gendrau‐Sanclemente, N., Abuasaker, B., Ruiz-Fariña, T., Barceló, C., Cuatrecasas, M., Bosch, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01967-3 · Cited by 13
Owusu, B. Y., Vaid, M., Kaler, P., & Klampfer, L. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s25247 · Cited by 13
Tunçer, S., Cagatay, S. T., Keşküş, A. G., Çolakoğlu, M., Konu, Ö., & Banerjee, S. (2016) · Cell Proliferation · doi:10.1111/cpr.12267 · Cited by 13
Sefrioui, D., Vermeulin, T., Blanchard, F., Chapusot, C., Beaussire, L., Armengol‐Debeir, L., Sesboüé, R., Gangloff, A., Hebbar, M., Copin, M., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30584 · Cited by 13
Kumar, R., Raman, R., Kotapalli, V., Gowrishankar, S., Pyne, S., Pollack, J. R., & Bashyam, M. D. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1607-4 · Cited by 15
Jia, Y., Feng, G., Chen, S., Li, W., Jia, Z., Wang, J., Li, H., Hong, S., & Dai, F. (2024) · Journal of Cancer · doi:10.7150/jca.94630 · Cited by 12
Personalized risk stratification in colorectal cancer via PIANOS system
Cai, D., Qi, H., Yang, Q., Li, H., Li, C., Hu, C., Gai, B., Zhang, X., Mao, Y., Gao, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61713-1 · Cited by 12
Hussien, M. T., Helmy, E., Elsaba, T. M., Elkady, A., Alrefai, H., & Hetta, H. F. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.6.1573 · Cited by 12
Miao, Y., Su, B., Tang, X., Wang, J., Quan, W., Chen, Y., & Mi, D. (2022) · IET Systems Biology · doi:10.1049/syb2.12040 · Cited by 12
RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells
Palassin, P., Lapierre, M., Bonnet, S., Pillaire, M., Győrffy, B., Teyssier, C., Jalaguier, S., Hoffmann, J., Cavaillès, V., & Castet‐Nicolas, A. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.133 · Cited by 12
Zhang, J., Wu, Y., Mu, J., Xin, D., Wang, L., Fan, Y., Zhang, S., & Xu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.954226 · Cited by 12
Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas
García-Cárdenas, J. M., Armendáriz‐Castillo, I., García-Cárdenas, N., Pesantez-Coronel, D., López‐Cortés, A., Indacochea, A., & Guerrero, S. X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1088057 · Cited by 12
Pan-cancer analysis of cuproptosis-promoting gene signature from multiple perspectives
Ma, J., Gong, B., & Zhao, Q. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01108-y · Cited by 12
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype
Cuesta-Borràs, E., Salvans, C., Arqués, O., Chicote, I., Ramírez, L., Cabellos, L., Martínez‐Quintanilla, J., Mur-Espinosa, A., García‐Álvarez, A., Hernando, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112927 · Cited by 12
Hong, W.-F., Zhu, D., Chen, Y., Shen, X., Cui, Y., Du, S., Liu, T., & Liang, L. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216460 · Cited by 12
Mouillet‐Richard, S., Gougèlet, A., Passet, B., Brochard, C., Corre, D. L., Pitasi, C. L., Joubel, C., Sroussi, M., Gallois, C., Lavergne, J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05164-0 · Cited by 12
Self-citationTang, J., Liang, M., Qin, F., Qin, Y., Wang, D., Huang, L., Cao, Y., Huang, Z., & Yin, Y. (2024) · Immunobiology · doi:10.1016/j.imbio.2024.152805 · Cited by 12
Chuang, P.-K., Chang, K.-F., Chang, C.-H., Chen, T., Wu, Y., Lin, H.-R., Wu, C.-J., Wu, C., Ho, Y., Lin, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041648 · Cited by 12
Translating colorectal cancer genetics into clinically useful biomarkers
Morley-Bunker, A. E., Walker, L. C., Currie, M. J., Pearson, J. F., & Eglinton, T. (2016) · Colorectal Disease · doi:10.1111/codi.13334 · Cited by 12
McNew, K. L., Whipple, W. J., Mehta, A. K., Grant, T. J., Ray, L. C., Kenny, C. J., & Singh, A. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0173 · Cited by 12
y Cajal, S. R., Hümmer, S., Peg, V., Matías‐Guiu, X., de Torres, I. M., Castellví, J., Martínez-Sáez, E. A., & Hernández‐Losa, J. (2019) · Histopathology · doi:10.1111/his.13828 · Cited by 12
Transcriptomic Profiling for the Autophagy Pathway in Colorectal Cancer
Gil, J., Karpiński, P., & Sasiadek, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197101 · Cited by 12
Xiang, R., & Fu, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-78228-y · Cited by 13
Li, X., Xie, M., Yin, S., Xiong, Z., Mao, C., Zhang, F., Chen, H., Jin, L., Lan, P., & Lian, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.666003 · Cited by 12
Seo, M.-K., Kang, H., & Kim, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-10182-3 · Cited by 12
GPER Agonist G1 Prevents Wnt-Induced JUN Upregulation in HT29 Colorectal Cancer Cells
Abancens, M., Harvey, B. J., & McBryan, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012581 · Cited by 12
Prognostic risk analysis related to radioresistance genes in colorectal cancer
Qin, H., Zhang, H., Li, H., Xu, Q., Sun, W., Zhang, S., Zhang, X., Zhu, S., & Wang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1100481 · Cited by 12
Dai, Z., Zhang, J., Xu, W., Du, P., Wang, Z., & Liu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076054 · Cited by 12
Paquet, É. R., Cui, J., Davidson, D. L., Pietrosemoli, N., Hassan, H. H., Tsofack, S. P., Maltais, A., Hallett, M. T., Delorenzi, M., Batist, G., et al. (2015) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.17 · Cited by 12
A novel approach for automatic gene selection and classification of gene based colon cancer datasets
Rathore, S., Iftikhar, M. A., & Hussain, M. (2014) · International Conference on Emerging Technologies · doi:10.1109/icet.2014.7021014 · Cited by 12
Huang, M., Lin, C., Huang, C., Tsai, H., Huang, C., Yeh, Y., Chai, C., & Wang, J. (2015) · World Journal of Surgery · doi:10.1007/s00268-014-2917-0 · Cited by 12
A universal molecular prognostic score for gastrointestinal tumors
Shimizu, H., & Nakayama, K. I. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00172-1 · Cited by 12
Chen, A., Liu, Z., Wu, Q., & Li, H. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01111-1 · Cited by 12
Darbo, É., Pérot, G., Darmusey, L., Guellec, S. L., Leroy, L., Gaston, L., Desplat, N., Thébault, N., Merle, C., Rochaix, P., et al. (2023) · Cancers · doi:10.3390/cancers15020534 · Cited by 12
Curated compendium of human transcriptional biomarker data
Golightly, N. P., Bell, A. D., Bischoff, A. I., Hollingsworth, P., & Piccolo, S. (2018) · Scientific Data · doi:10.1038/sdata.2018.66 · Cited by 12
Zhao, Q., Huang, R., Wang, C., Hu, J., Nie, R. C., Jian, R., Wang, Y., Wang, D., Liang, C., Chen, Y., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.01.015 · Cited by 11
Escobar, D., Jones, R., Gao, J., Sun, L., Liao, J., & Yang, G. (2020) · Human Pathology · doi:10.1016/j.humpath.2020.08.002 · Cited by 11
Sahar, N.-E., Qadir, J., Riaz, S. K., Bagabir, S. A., Muneer, Z., Sheikh, A. K., Waqar, S. H., Pellicano, R., Fagoonee, S., Haque, S., et al. (2022) · Minerva Medica · doi:10.23736/s0026-4806.22.07981-2 · Cited by 11
Lu, J. N., Annunziata, F., Širvinskas, D., Omrani, O., Li, H., Rasa, S. M. M., Křepelová, A., Adam, L., & Neri, F. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00867-2 · Cited by 11
Satow, R., Suzuki, Y., Asada, S., Ota, S., Idogawa, M., Kubota, S., Ikeo, N., Yoneda, A., & Fukami, K. (2022) · iScience · doi:10.1016/j.isci.2022.105501 · Cited by 11
The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer
Zheng, G., Zhang, G.-J., Zhao, Y., & Zheng, Z. (2023) · Journal of Oncology · doi:10.1155/2023/9315027 · Cited by 11
van Gogh, M., Garzon, J. F. G., Şahin, D., Knopfová, L., Beneš, P., Boyman, O., Jurišica, I., & Borsig, L. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0912 · Cited by 11
Liu, W., Luo, X., Zhang, Z., Chen, Y., Dai, Y., Deng, J., Yang, C., & Liu, H. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03658-w · Cited by 11
Xu, H., Cui, H., Weng, S., Zhang, Y., Wang, L., Xing, Z., Han, X., & Liu, Z. (2024) · Communications Biology · doi:10.1038/s42003-024-05980-6 · Cited by 11
The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer
Trimaglio, G., Sneperger, T., Raymond, B. B. A., Gilles, N., Näser, E., Locard‐Paulet, M., Ijsselsteijn, M. E., Brouwer, T. P., Ecalard, R., Roelands, J. P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57941-y · Cited by 11
Hu, S., Qin, J., Ding, M., Gao, R. C., Xiao, Q., Lou, J., Chen, Y., Wang, S., & Pan, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167535 · Cited by 11
Li, J., Ye, L., Sun, P., Zheng, F., Ruge, F., Satherley, L. K., Feng, Y., Zhao, H., Du, G., Wang, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15439 · Cited by 11
Gene Selection for the Discrimination of Colorectal Cancer
Wang, W., Xie, G., Ren, Z., Xie, T., & Li, J. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191119105209 · Cited by 11
Zhou, Y., Long, Y., Chen, Y., Liu, J., Pu, D., Huang, J., Bi, F., Li, Q., Gou, H., & Qiu, M. (2021) · Cancer Medicine · doi:10.1002/cam4.3876 · Cited by 11
Bazzi, S. I., El-Darzi, E., McDowell, T. L., Modjtahedi, H., Mudan, S., Achkar, M., Akle, C. A., Kadara, H. N., & Bahr, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137214 · Cited by 11
Adam, R., Blomberg, I., ten Hoorn, S., Bijlsma, M. F., & Vermeulen, L. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103428 · Cited by 12
Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a
Liu, F., Bouznad, N., Kaller, M., Shi, X., König, J., Jaeckel, S., & Hermeking, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75503 · Cited by 11
Real‐world data in the molecular era—finding the reality in the real world
Dickson, D., & Pfeifer, J. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.300 · Cited by 11
Immunotherapy in the treatment of colorectal cancer: a new kid on the block
Spallanzani, A., Gelsomino, F., Caputo, F., Santini, C., Andrikou, K., Orsi, G., Rimini, M., Pipitone, S., Riggi, L., Bardasi, C., et al. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.31 · Cited by 11
Catalano, V., Bergamo, F., Cremolini, C., Vincenzi, B., Negri, F., Giordani, P., Alessandroni, P., Intini, R., Stragliotto, S., Rossini, D., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03077-w · Cited by 11
Beck, M., Baranger, M., Moufok-Sadoun, A., Bersuder, E., Hinkel, I., Mellitzer, G., Martin, E., Marisa, L., Duluc, I., de Reyniès, A., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01546-y · Cited by 11
Self-citationRuan, G., Wang, S., Zhu, L., Liao, X., Wang, X., Liao, C., Yan, L., Xie, H., Gong, Y., Gan, J., et al. (2021) · Aging · doi:10.18632/aging.202935 · Cited by 11
Shembrey, C., Behrenbruch, C., Loveday, B. P. T., Heriot, A. G., Foroutan, M., & Hollande, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011247 · Cited by 11
Dunne, P. D., Coleman, H. G., Bankhead, P., Alderdice, M., Gray, R. T., McQuaid, S., Bingham, V., Loughrey, M. B., James, J. A., McCorry, A. M. B., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24481 · Cited by 10
Pancancer network analysis reveals key master regulators for cancer invasiveness
Jethalia, M., Jani, S. P., Ceccarelli, M., & Mall, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04435-6 · Cited by 10
Zhou, S., Yu, L., Zhao, J., Xiao, Q., Sun, J., Wang, L., Zhou, Y., Lu, Y., Dunlop, M. G., Τheodoratou, E., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04074-2 · Cited by 10
Bouazzaoui, L. E., Bugter, J. M., Küçükköse, E., Verheem, A., Post, J. B., Fenderico, N., Rinkes, I. H. M. B., Snippert, H. J. G., Maurice, M. M., & Kranenburg, O. (2025) · iScience · doi:10.1016/j.isci.2025.112905 · Cited by 10
Strelez, C., Battaglin, F., Perez, R. G., Yang, Y., Cherry, C., Millstein, J., Yoon, A. Y., Chlystek, J. S., Canfield, E. J., Haliday, B., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03546-2 · Cited by 10
Metadata
- Authors
- Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., Kirzin, S., Chazal, M., Fléjou, J.-F., Benchimol, D., Berger, A., Lagarde, A., Pencreach, E., Piard, F., Elias, D., Parc, Y., Olschwang, S., Milano, G., Laurent-Puig, P., & Boige, V.
- Affiliations
- Inserm (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- La Ligue Contre le Cancer (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Hôpital Européen Georges-Pompidou (FR)
- CHU Dijon Bourgogne (FR)
- Institut Gustave Roussy (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-21
- Volume
- 10
- Issue
- 5
- Pages
- e1001453
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3660251
- OpenAlex
- W2154941270
- Cited by
- 1,507
- References
- 40
- Citations by year
- 2026: 84 · 2025: 111 · 2024: 108 · 2023: 142 · 2022: 145 · 2021: 194 · 2020: 131 · 2019: 126 · 2018: 131 · 2017: 108 · 2016: 90 · 2015: 74 · 2014: 53 · 2013: 8
- FWCI
- 56.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- American Association for Cancer Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- colon cancer, molecular subtypes, gene expression signatures, mismatch repair deficiency, chromosomal instability, KRAS mutation, BRAF mutation, TP53 mutation, CpG island methylator phenotype, Wnt signaling, relapse-free survival, prognosis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Colonic Neoplasms, Female, France, Genetic Testing, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, RNA, Messenger, Time Factors, Biomarkers, Tumor, Reproducibility of Results, Gene Expression Regulation, Neoplastic, Multivariate Analysis, Cluster Analysis, Chi-Square Distribution, Logistic Models, Proportional Hazards Models, Risk Assessment, Genetic Predisposition to Disease, Gene Expression Profiling, Kaplan-Meier Estimate, Young Adult, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.